Fingerprint
Dive into the research topics of '21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer
Charles E. Geyer, Gong Tang, Eleftherios P. Mamounas, Priya Rastogi, Soonmyung Paik, Steven Shak, Frederick L. Baehner, Michael Crager, D. Lawrence Wickerham, Joseph P. Costantino, Norman Wolmark
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations